يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Michel Toungouz Nevessignsky"', وقت الاستعلام: 1.38s تنقيح النتائج
  1. 1
    دورية أكاديمية
    A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

    المؤلفون: Timothy Devos, Tatjana Geukens, Alexander Schauvlieghe, Kevin K. Ariën, Cyril Barbezange, Myriam Cleeren, Veerle Compernolle, Nicolas Dauby, Daniël Desmecht, David Grimaldi, Bart N. Lambrecht, Anne Luyten, Piet Maes, Michel Moutschen, Marta Romano, Lucie Seyler, Michel Toungouz Nevessignsky, Katleen Vandenberghe, Johan van Griensven, Geert Verbeke, Erika Vlieghe, Jean Cyr Yombi, Laurens Liesenborghs, Peter Verhamme, Geert Meyfroidt

    المصدر: Trials, Vol 21, Iss 1, Pp 1-15 (2020)

    مصطلحات موضوعية: SARS-CoV-2, COVID-19, Convalescent plasma, Antibodies, Immunity, Medicine (General), R5-920

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/1745-6215

    URL الوصول: https://doaj.org/article/e2c17a0f94ae4fa2bd3259accdd55070

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

    المؤلفون: Timothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, Kevin K. Ariën, Cyril Barbezange, Myriam Cleeren, Veerle Compernolle, Nicolas Dauby, Daniël Desmecht, David Grimaldi, Bart N. Lambrecht, Anne Luyten, Piet Maes, Michel Moutschen, Marta Romano, Lucie Seyler, Michel Toungouz Nevessignsky, Katleen Vandenberghe, Johan van Griensven, Geert Verbeke, Erika Vlieghe, Jean Cyr Yombi, Laurens Liesenborghs, Peter Verhamme, Geert Meyfroidt

    المساهمون: UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre de prise en charge (H.I.V.), UCL - (SLuc) Département de médecine interne et services associés, UCL - (SLuc) Service d'orthopédie et de traumatologie de l'appareil locomoteur, Mathematics, Faculty of Sciences and Bioengineering Sciences, Internal Medicine

    المصدر: Trials, Vol 21, Iss 1, Pp 1-1 (2020)
    Trials, Vol. 21, no.1, p. 1 (2020)
    Trials

    مصطلحات موضوعية: Adult, Male, lcsh:R5-920, SARS-CoV-2, Immunization, Passive, Correction, COVID-19, Medicine (miscellaneous), Standard of Care, Antibodies, Viral, Combined Modality Therapy, Respiration, Artificial, Global Burden of Disease, Hospitalization, Treatment Outcome, Belgium, Humans, Female, Pharmacology (medical), Mortality, Safety, lcsh:Medicine (General), COVID-19 Serotherapy

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6de4836c5c1f3d67e3e8e59b163c1dd6
    https://doaj.org/article/30aec88a445e44dab92599746ef9197f

    Find this article in full text from ProQuest
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء